Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 301 - 321
Published: Jan. 1, 2025
Language: Английский
Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 301 - 321
Published: Jan. 1, 2025
Language: Английский
Human Vaccines & Immunotherapeutics, Journal Year: 2024, Volume and Issue: 20(1)
Published: Aug. 19, 2024
Respiratory syncytial virus (RSV) is an important cause of respiratory illness. While most attention paid to childhood infection, the RSV burden in adults ≥60 y should also be considered. In Brazil, this generally underrecognized, where greater focus toward other pathogens. This article presents insights from a multidisciplinary panel gathered review epidemiologic data and current diagnostic approaches Brazil (and their limitations) develop communication strategies improve knowledge awareness. National surveillance indicate steady increase cases RSV-related severe acute illness (RSV-SARI) those aged recent years, with high fatality rates (>30%). Routine testing older individuals symptoms relatively low. Educational activities targeted health-care professionals general public are critical raising awareness importance individuals, particularly as protective vaccines now available.
Language: Английский
Citations
6Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 301 - 321
Published: Jan. 1, 2025
Language: Английский
Citations
0